We’ve heard more than enough about the health of the rotation going into Spring Training. But there’s still another key piece to a Mets championship run that needs its own attention.
Yoenis Cespedes has long cemented himself as a hero to Mets fans. Few will forget how he essentially carried the team into the playoffs in 2015. And we all held our breaths that offseason in hopes that the organization would actually do the right thing and pay the man.
But now Cespedes is coming into the second year of his 4-year deal, and some are beginning to ask the question: “Was it really worth it?”
Yes. Yes. A thousand times yes. While it’s true that Cespedes is starting to age, last season is what I would consider a minor hiccup in what he’s able to provide for this team on a regular basis. A hiccup, only in the sense of injuries. (His legs are made of glass?)
In 2016 he was the 31 home run guy. Last year, amidst injuries and all, he was still able to put up an OPS of .892. Just slightly higher than that of his 2016 season, where he played 132 games and posted an OPS of .884. Sure, it’s not a dramatic difference. But still important to note that even in the 81 games he played last year, Cespedes was still able to produce. Both his SLG and AVG were up last year as well, at .540 and .292 respectively. His 2017 numbers were even just slightly higher or at about the same as they were for his 2015 numbers between New York and Detroit.
So what does this all mean? It means that Yo has plenty left in the tank to put on a show in Queens. Truthfully, his health is going to be just as crucial next season as Noah Syndergaard‘s and the rest of that rotation. It’s far too early to hit the panic button and call Cespedes’ deal a failure.